NEAT1 and prostate cancer: NEAT1/m6A has been reported to facilitate the oncogenic function of the novel CYCLINL1/CDK19 complex in patient-derived metastatic bone xenograft (PDX) and that NEAT1/m6A plays a vital role in regulating the progression of prostate cancer.